Histo-blood group glycans in the context of personalized medicine☆

  title={Histo-blood group glycans in the context of personalized medicine☆},
  author={Viktoria Dotz and Manfred Wuhrer},
  journal={Biochimica et Biophysica Acta. General Subjects},
  pages={1596 - 1607}
  • V. DotzM. Wuhrer
  • Published 31 December 2015
  • Biology, Medicine
  • Biochimica et Biophysica Acta. General Subjects

Figures and Tables from this paper

FORS, a new histo-blood group: A current review

It’s extremely important the study of this histo-blood group is carried out, considering all its potentialities, contributing to a better characterization of this Histo- blood group.

Role of Antigen Determinants a and B of AB0 Blood Group System in Human Disease Development (Mini Review)

The review provides synthesis of association of such pathological conditions as coronary heart disease, thromboembolic complications, tumors of various localizations, inflammatory and destructive oral diseases, psychiatric and some infectious diseases with the presence or absence of antigenic determinants A and B.

[Blood group and human diseases (review of literature).]

Clinical significance of the definition of group typing not only for selection of blood and its components during transfusion and transplantation, but also for diagnostics, determination of risk group and tactics for treatment patients with different nosologies is demonstrated.

Therapeutics through glycobiology: an approach for targeted elimination of malaria

Understanding of post translational modification of proteins involved in the parasite-host interactions should identify viable antimalarial strategies.

Glycosylation in health and disease

The broad role of glycans in immunity, cancer, xenotransplantation and glomerular filtration and the potential of ‘glycomedicine’ are discussed.

ABO, H, Lewis and Secretor histo-blood group-like carbohydrates in pathogenic and non-pathogenic invertebrates

This text revised the literature and offers a tentative explanation for the presence of histo-blood group-like carbohydrates in pathogenic and non-pathogenic invertebrates and its importance in terms of evolution.

Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives

This review summarizes the strategies developed in cancer immunotherapy targeting TACAs, analyzing molecular and cellular mechanisms and state-of-the-art methods in clinical oncology.

Epigenetic Bases of Aberrant Glycosylation in Cancer

From a therapeutic perspective aimed at the normalization of the malignant glycome, it appears that miRNA targeting of cancer-deranged glycogenes can be a more specific and promising approach than the use of drugs, which broad target methylation/acetylation.

ABO blood group antigen therapy: a potential new strategy against solid tumors

In vitro cell-based experiments proved that tumor cells expressing blood group A antigens showed significantly inhibited cell proliferation when added to serum containing bloodgroup A antibodies, proving that the ABO blood group antigen may become a powerful tool for the treatment of tumors in patients.



ABH and Related Histo‐Blood Group Antigens; Immunochemical Differences in Carrier Isotypes and Their Distribution 1

This review summarizes present knowledge of the chemistry of histo‐blood group ABH and related antigens and indicates that at least six types of A determinants can be distinguished by qualitatively different classes of antibody.

Human milk oligosaccharides and Lewis blood group: individual high-throughput sample profiling to enhance conclusions from functional studies.

The matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiles of oligosaccharides in individual milk samples exemplify the advantages and the limitations of sample assignment to distinct groups.

ABO blood group antigens in oral mucosa. What is new?

  • E. Dabelsteen
  • Biology, Medicine
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • 2002
Several studies have shown that loss of A and B antigen expression is associated with increased cell motility, invasion in matrigel, and tumourigenecity in syngenic animals, and some studies suggest that the relationship between expression of blood group antigens and cell Motility can be explained by different degrees of glycosylation of integrins.

Fucosyltransferase 2: A Genetic Risk Factor for Primary Sclerosing Cholangitis and Crohn's Disease—A Comprehensive Review

The biology of F UT2 will be discussed as well as hypotheses to explain the role of FUT2 in the pathophysiology of PSC and Crohn’s disease are discussed.

Blood groups and susceptibility to virus infection: new developments

  • D. Branch
  • Biology, Medicine
    Current opinion in hematology
  • 2010
The Pk/Gb3 histo-blood group antigen is the first described cell surface expressed natural resistance factor for prevention of HIV infection.

ABO blood group glycans modulate sialic acid recognition on erythrocytes.

It is shown that by stabilizing such structures ABH antigens can also modulate sialic acid-mediated interaction of pathogens such as Plasmodium falciparum malarial parasite, and can noncovalently alter the presentation of other cell surface glycans to cognate-binding proteins, without themselves being a direct ligand.

Histo‐Blood Group Antigens as Allo‐ and Autoantigens

This paper is an up‐to‐date analysis of the importance of HBG systems in the alloimmunity of transplantation and autoimmune events, such as hemolytic anemia.

The human P(k) histo-blood group antigen provides protection against HIV-1 infection.

It is concluded that P(k) expression strongly influences susceptibility to HIV-1 infection, which implicates P( k) as a new endogenous cell-surface factor that may provide protection against HIV- 1 infection.

Noroviruses and histo‐blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution

Studies of NoV–HBGA interactions together with phylogenetic analyses and the epidemiologic survey of strains indicate that NoV transmission and evolution depend on both the establishment of herd immunity and the genetic resistance of many individuals, which confers herd innate protection by restricting NoV circulation.